Anne Samuel

Stock Analyst at JP Morgan

(2.58)
# 2,319
Out of 5,056 analysts
71
Total ratings
56.82%
Success rate
0.31%
Average return

Stocks Rated by Anne Samuel

Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13$7
Current: $3.85
Upside: +81.82%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125$126
Current: $102.40
Upside: +23.05%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274$290
Current: $275.51
Upside: +5.26%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23$25
Current: $25.89
Upside: -3.44%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63$60
Current: $48.31
Upside: +24.20%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232$177
Current: $217.97
Upside: -18.79%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44$36
Current: $34.49
Upside: +4.38%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27$28
Current: $19.85
Upside: +41.06%
Premier
Sep 9, 2024
Maintains: Neutral
Price Target: $21$19
Current: $28.20
Upside: -32.61%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19$21
Current: $21.70
Upside: -3.23%
Maintains: Overweight
Price Target: $10$13
Current: $2.23
Upside: +484.27%
Maintains: Overweight
Price Target: $24$27
Current: $34.73
Upside: -22.26%
Downgrades: Underweight
Price Target: $7$5
Current: $2.63
Upside: +90.48%